Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
[Maintenance therapy for colorectal cancer]
Shigeo Yamaguchi1, Shunsuke Kato
1Dept. of Medical Oncology, Juntendo University.
Maintenance chemotherapy for advanced colorectal cancer focuses on preventing toxicity and maintaining quality of life. Bevacizumab shows promise, but optimal drug selection and patient identification for maintenance therapy remain debated topics.
Area of Science:
- Oncology
- Gastroenterology
- Clinical Pharmacology
Context:
- Advanced colorectal cancer treatment often involves chemotherapy, with a focus on quality of life and toxicity management.
- The FOLFOX regimen combined with bevacizumab is a common first-line therapy in Japan.
- Chemotherapy-induced side effects like neuropathy can lead to treatment withdrawal.
Purpose:
- To review the role of maintenance chemotherapy in advanced colorectal cancer.
- To discuss the effectiveness of bevacizumab-based maintenance strategies.
- To highlight the ongoing controversy regarding optimal drug selection and patient stratification for maintenance therapy.
Summary:
- Trials suggest benefits of maintenance chemotherapy for advanced colorectal cancer, emphasizing quality of life over aggressive regimens.
- Bevacizumab has demonstrated efficacy in maintenance and beyond progression settings.
- Current research lacks direct comparisons between cytotoxic agents and bevacizumab for maintenance therapy.
Impact:
- Informs clinical decision-making regarding maintenance therapy selection in advanced colorectal cancer.
- Identifies gaps in evidence for optimizing bevacizumab use and patient selection.
- Contributes to the ongoing discussion on balancing treatment efficacy with patient well-being.
More Related Videos
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Constipation-Predominant IBS
Treatment Resistant Cancers
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...